Archives

by in
Entry Author Date Location
Nimbus Discovery, Shire to Co-Develop Oral Rare Disease Drugs 05/08/13 Boston
Repligen in Drug Development Licensing Deal with Pfizer 01/04/13 Boston
Synageva BioPharma Announces $80 Million Stock Offering 01/03/13 Boston
Amicus-GlaxoSmithkline Drug for Fabry Disease Fails Clinical Trial 12/20/12 New York
Promedior Joins Ranks of Woman-Helmed Biotechs in Massachusetts 12/19/12 Boston
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Alnylam Gets $22.5M From Genzyme for Asia Rights to Amyloidosis Drug 10/22/12 Boston
Rare Disease Science Challenge Offers $400,000 in Cash & Services 10/15/12 San Diego
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Two Years After Rising from Ashes, Aegerion Preps for Drug Debut 08/09/12 Boston
NPS Rallies as Good News Flows for Two Rare-Disease Drugs 06/25/12 New York
Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug 05/23/12 Boston
Pfizer Takes on Genzyme With New Gaucher Drug 05/02/12 Boston
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup 04/03/12 New York
Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments 01/11/12 New York
Sanofi Names David Meeker New CEO of Genzyme, Will Report to Viehbacher 10/24/11 Boston
Synageva to Merge With Trimeris 06/13/11 Boston
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit 05/12/11 New York
Zacharon Nabs $210M Deal With Pfizer to Tackle Orphan Diseases 04/07/11 San Diego
Synageva Grabs $25M for Rare Diseases Drug Pipeline 03/21/11 Boston
Edimer, Third Rock’s Bet on Rare Diseases, Aims to Begin First Human Tests 03/15/11 Boston
Report: Genzyme Chief Could Reap $221.2M in Sanofi Deal 03/08/11 Boston
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche 03/03/11 Boston
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders 03/01/11 Boston
Genzyme Rival Fails to Get FDA Approval 02/25/11 Boston
Alexion Pharma Gobbles Up Taligen in $111M Buyout 01/31/11 Boston
Genzyme to Let Diagnostics Unit Loose for $265M 11/18/10 Boston
PerkinElmer Expects to Make Acquisitions After $500M Business Sale: CEO Talks Boston-Area Talent and Growth in Software, Imaging 09/13/10 Boston
VMware Makes Two Acquisitions, Mascoma Picks Up SunOpta Unit, Vela Gets $6M, & More Boston-Area Deals News 09/08/10 Boston
PerkinElmer Sells Unit for $500M, Aveo Stock Climbs, Pfizer Buys FoldRx, & More Boston-Area Life Sciences News 09/03/10 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.